About 85% of people with multiple sclerosis (MS) present with a clinically isolated syndrome (CIS) commonly affecting optic nerves, the spinal cord, the cerebellum or the brainstem. There is also evidence that early MRI features at least partly predict disability progression in the short (<2-3 years) and longer term (≥5 years).
| INTRODUC TI ON
About 85% of people with multiple sclerosis (MS) present with a clinically isolated syndrome (CIS) commonly affecting optic nerves, the spinal cord, the cerebellum or the brainstem. 1 Magnetic resonance imaging (MRI) has an established role in the diagnosis of MS, estimating the risk of developing MS following a CIS 2 and assessing MS activity when making treatment decisions. 3, 4 There is also evidence that early MRI features at least partly predict disability progression in the short (<2-3 years) and longer term (≥5 years).
5,6
Disability prognosis is of great importance to people with a CIS, helping them to make informed treatment decisions. 7, 8 Recent work on patients' attitudes towards MRI has shown marked interest in the information provided by results from MRI scans, although the use of this information in MS management varies considerably at a national and international level. 7 Beliefs, accessibility and costs seem to determine MRI usage more so than a clear evidence base.
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Magnetic resonance imaging (MRI) is the key prognostic tool in people with a clinically isolated syndrome (CIS). There is increasing interest in treating people following a CIS in the hope that conversion to multiple sclerosis (MS) will be prevented and future disability reduced. So far, the prognostic value of MRI for disability following a CIS has not been evaluated systematically. We systematically searched MEDLINE and EMBASE. Cohort studies were selected if they reported associations of MRI and disability following a CIS, included at least 50 people with a CIS at baseline, had at least 5 years of follow-up and obtained at least one structural MRI measurement (T1 lesions, T2 lesions, T1 contrast-enhancing lesions or brain atrophy). We assessed the studies for quality and rated the completeness of MRI reporting. In total, 13 studies were identified reporting on the following: T2 lesion number and volume, T2 infratentorial lesion number and volume, T1 contrast-enhancing lesions and grey matter fraction. T2 brain lesion number determined soon after the occurrence of a CIS was associated with disability progression after 5-7 years, with an increased risk when 10 or more lesions were present. Infratentorial lesions were also associated with a higher risk of subsequent disability. The number and distribution of MRI-visible lesions soon after a CIS are associated with disability later on, and may offer additional useful information when making treatment decisions in people with early MS.
Further work is required to determine whether other measures have a higher predictive potential.
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There are literature reviews on MRI factors and their association with the risk of developing MS following a CIS 9, 10 ; however, most do not fulfil systematic review criteria. 11, 12 To the best of our knowledge, no systematic review has assessed the prognostic value of MRI for disability following a CIS. The present systematic review aimed to fill this gap.
| ME THODS
To maximize the amount of information we could gather about outcomes following a CIS, and noting that studies on MS also include information about CIS (ie those who convert to MS), we performed a literature search to identify studies assessing the prognostic role of MRI in people who had had a CIS or MS. For completeness, the literature search was performed for all disease courses of MS, but only findings related to early relapse-onset MS (CIS) were included.
| Criteria for considering studies for this systematic review
We included retrospective and prospective longitudinal studies that reported on associations of the brain and/or spinal MRI and disability following a CIS. As disability is usually low following recovery from a CIS and the predictive value of the short-term disability evolution within the first years is low, 13 only studies with a follow-up ≥5 years were included to assess disease progression. Placebo arms of randomized controlled MS long-term immunotherapy treatment studies were not considered, because the placebo arms usually switch to treatment after 2 years.
14,15
| Cohort size
Studies were eligible for inclusion when they included ≥50 people with a CIS at baseline. As we did not expect sample size calculations for the cohort studies, but rather convenient samples, we chose to only include studies with at least 50 people to receive meaningful results. While we included studies with at least 5 years of follow-up, we expected a considerable loss to follow-up increasing the risk of substantial selection bias in very small cohorts. Cohorts only consisting of people under 18 years old were not included.
| MRI prognostic factors
At least one of the following MRI measurements had to be assessed at baseline: number or volume of T1 lesions, number or volume of T2 lesions, T1 contrast-enhancing lesions or brain volume. Where available, the relative prognostic value of regional lesion accrual was also considered, for example supra-and infratentorial location of lesions.
Studies, which reported on new MRI techniques, such as spectroscopy, or prognostic models only were not included.
| Primary outcome measures
The primary outcome was disability progression assessed by the expanded disability status scale (EDSS) 16 in association with the prognostic factor (MRI). Studies that assessed mean EDSS and time to reach EDSS 3 or 6 were included. Studies were only included in case they reported EDSS as an outcome.
| Secondary outcome measures
We also assessed transition from a CIS to clinically definite MS (CDMS), the development of secondary progressive MS (SPMS) and mortality.
| Search methods
Electronic searches were carried out in MEDLINE and EMBASE (via OVID). We performed a search on all disease courses and combined the term "multiple sclerosis" and variations with the term "MRI" and variations using the Boolean operator AND. Search filters on prognosis were applied. 17, 18 The MEDLINE search strategy (Material S1) was adapted for EMBASE. We included published studies until May
(EMBASE) and accordingly September 2017 (MEDLINE). The
full text had to be available in English or German language. A handsearch of reference lists of the included studies was performed to detect further eligible studies. EndNote X5-X7 was used for bibliographic management including duplicate removal.
| Data collection and analysis
To minimize selection bias, paired reviewers (JB/SK, CH/AR) independently screened the search findings (title/abstract). The reviewers were overinclusive. Full texts were examined independently by paired reviewers (JB/SK, CH/AR) according to the predefined inclusion criteria. Nonagreement of including or excluding a study was resolved by discussion.
Paired researchers (AMK/AR, CH/AR) independently extracted demographic, disease-specific and outcome data. Results were compared by the researchers. All numbers of included studies assessing disability, CDMS or SPMS in relation to baseline MRI data were extracted. Additional results, for example from regression analyses, were considered.
Paired researchers (AMK/AR and CH/AR) independently assessed the quality of included studies. Different results were resolved by discussion.
We used the "Quality In Prognosis Studies" (QUIPS) tool 19, 20 to assess the validity of the included studies. With this tool, markers on disease activity and outcomes (eg disability progression) can be assessed separately for potential bias. It comprises six domains: participation, attrition, prognostic factor measurement (in our case MRI measurements), outcome measurement, confounding and analysis.
A judgement concerning the related risk of bias will be assigned for each domain (yes, partly, no risk). Further, an afore-applied checklist was used to assess the quality and completeness of MRI reporting. 21 Heterogeneity in study designs and cohorts made it impossible to conduct robust meta-analyses. A scheme reaching from "strong evidence of effect" to "no evidence," proposed in a protocol for an exemplary prognostic review by the Cochrane group, 22 was used to illustrate the consistency and the strength of the results for the primary endpoint (Table 2) .
| RE SULTS

| Results of the search
A total of 3708 titles and abstracts were screened for inclusion ( Figure 1 ). In that stage, 3639 studies were excluded. In total, 69 studies, which potentially met the inclusion criteria, were assessed in full text. Of those, 13 studies 5, 6, [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] fulfilled the eligibility criteria. Further, 18 studies reported on the topic, but focussed on other disease courses, which are not subject of this publication.
| Descriptions of included cohorts and publications
Marked heterogeneity was found in study duration ranging from 5 to 20 years and MRI assessments (Material S2). Cohort study reports from two centres in London (two cohorts) and Barcelona (one cohort) and three publications on the long-term follow-up of a RCT on treatment of optic neuritis (ONTT) were included (see Material S2 and Tables 1 and 2 ). Baseline MRI scans were performed at the centre 3-5 months after a CIS diagnosis, after 12 months and then every 5 years. 5 The EDSS was assessed at each visit and only considered for analysis during stable periods as indicated by the authors. 5, 25, 26 CDMS was diagnosed according to the Poser criteria. In the first study, 25 175 patients were followed over 7 years. Another study 26 focused on the prognostic role of baseline infratentorial lesions by analysing a subgroup of 77 patients with infratentorial lesions out of a cohort including 246 patients retrospectively. The latest publication from 2015 reports on 1058 patients. 
| Quality assessment
Heterogeneity of studies was high due to different study designs 
| Study results
Mean patient age at baseline ranged from 29 to 32 years across the cohorts, with more women (approx. 67% overall). Results are presented separately for CIS and ON only. As we found very limited information on the transition to SPMS, data are presented in "comments and additional" results section of Table 1 and in the text.
No information about mortality following a CIS and its relationship with MRI was reported. For comparison with the MRI prognostic features predicting disability following a CIS, we also included MRI features predicting conversion to CDMS (Table 2 ), but as these have already been considered previously, 4,9,10 we do not further discuss these.
| Reported outcomes
In Table 1 , it is listed on which different prognostic factors and outcomes were reported by the included studies, besides disability and conversion to CDMS. For more details, see Table 2 and the reported results section on disability progression.
| Disability progression
For baseline MRI measures of lesions, we present the associations with outcomes according to years of follow-up. Details about the strength of associations between MRI outcomes and disability are provided in Table 3 . We present the numbers of people with disability progression according to MRI results (normal or abnormal) in Table 4 .
| CIS
| Lesions seen on baseline MRI
5-7 years
Morrisey 1993 Filippi (1994), 33 who reanalysed data from London I, 23 reported a correlation between total baseline T2 lesion volume and disability scores at follow-up (r = 0.62, P < 0.0001). In addition, Filippi 33 (London I) showed that next to the total lesion volume also the infratentorial lesion volume at baseline appeared higher in patients with an EDSS ≥3 than in those with an EDSS score <3 (P < 0.0001) after 5 years.
Tintore (2015) 5 (Barcelona, median follow-up: 6.8 years) found that the risk of an increased EDSS was higher in patients with 10 or more brain lesions (adjusted hazard ratio 2.9, 95% CI 1.4-6.0). showed that the number of T2 lesions at baseline was related to the EDSS after 10 years (r = 0.45, P < 0.001).
In the London cohort I, 28 33 Sailer 1999, 27 Brex 2002, 28 Fisniku 2008 6 T2 infratentorial lesion volume Filippi 1994, 33 Sailer 1999, 27 Conversion to SPMS O'Riordan 1998, 24 Sailer, 1999, 27 Brex 2002, 28 The total and infratentorial T2LV at BL were higher in patients, who developed CDMS (P < 0.0001). Compared to 44 of 64 (69%) without infratentorial lesions, 18 of 20 patients (90%) with infratentorial lesions developed CDMS. Fourteen of those 18 patients had a total T2LV >1.23 cm³. The total and infratentorial T2LV at BL were higher in patients with an EDSS ≥3 than in those with an EDSS score <3 (P < 0.0001). The total BL T2LV correlated with the severity of disability at follow-up (r = 0.619, P < 0. There was a moderate correlation between infratentorial LV at BL and the total LV at 5 (r = 0.5, P = 0.001) and 10-year follow-up (r = 0.44, P = 0.006). The total LV at BL was associated with the disease type at 5 years (CIS, CPMS, or CDMS) (P = 0.0001, Kruskal-Wallis) and 10 years (CIS, CPMS, or CDMS, benign, RR, SP; P = 0.0001, Kruskal-Wallis) (r = 0.49, P < 0.001) years correlated weakly to moderately with change in EDSS after 20 years. 6 Results for the baseline T2 lesion number and EDSS status (>3 or ≥6) after 20 years are provided in Table 2 .
TA B L E 2 (Continued)
(
| Contrasting Barcelona and London cohort data on T2 lesions
In the Barcelona cohort, 5 having 4-9 lesions ( 
| Optic neuritis only
5-7 years
In the ONTT, 2 of 30 CDMS patients (7%) with no MRI lesions developed EDSS ≥3 compared with 10 of 42 CDMS patients (24%) having ≥3 lesions (P = 0.063). 30 Two of 20 patients (10%) with one to two lesions developed moderate or severe disability (EDSS score ≥3). 
8-14 years
The mean EDSS score of lesion-free patients (n = 34) after 10-12 years was 2.4 compared to 2.6 in patients with 1 or more lesions (n = 80). In the ONTT, no association between the disability and presence of lesions or no lesions in baseline MRI (P = 0.51) after 10-12 years was found. 29 Further, the number of lesions appeared unrelated to disability (r = 0.17, P = 0.14).
29
TA 
Infratentorial lesion volume
+/− n.r. n.r.
ON only cohorts 5-7 years 8-14 years 15 years
T2 lesion number +/− --T2 lesion volume n.r. n.r. n.r.
10 or more T2 lesions n.r. n.r. n.r.
Change in lesion volume n.r. n.r. n.r.
Infratentorial lesions +/− n.r. n.r.
Infratentorial lesion volume n.r. n.r. n.r.
+: moderate evidence of effect; +/−: limited evidence of effect; -: no evidence (22); n.r.: not reported (data was only considered, when P-values or confidence intervals were reported). TA B L E 4 Main findings: MRI lesions as a prognostic factor for disability (EDSS ≥3) 
years
In the ONTT, there was no association between the degree of disability after 15 years and number of brain lesions in the baseline MRI (r = 0.07). 31 
| D ISCUSS I ON
To the best of our knowledge, this is the first systematic review addressing the prognostic value of MRI for disability following a CIS.
The results illustrate that few studies assessed the prognostic MRI value beyond 5 years in people with a CIS. There is moderate evidence that the number of baseline lesions is associated with the EDSS after 5 years. 23, 25 In the larger cohort from Barcelona, 5 with a median follow-up of 6.8 years, it was found that the risk of an increased EDSS was higher in patients with 10 or more lesions.
Further, infratentorial, especially brainstem lesions seem to be linked with greater disability. It is known that lesion detection will increase when switching from 0.5 to 1.5 and further to 3.0 Tesla, with up to ~40% more T2 lesions detectable on a 3.0 Tesla scanner compared to 1.5 Tesla, [35] [36] [37] [38] [39] although its impact on correlations with disability has not been assessed. 40 Nonetheless, a higher detection rate seems not to lead to an earlier MS diagnosis, [39] [40] [41] [42] but this has to be confirmed for newer diagnostic criteria. 2, 43 In the Barcelona cohort, McDonald 2010 diagnostic criteria but not better lesion detection technology might have led to a higher percentage of patients diagnosed with MS and short-term low disability.
The importance of infratentorial lesions was recently readdressed in the MAGNIMS consensus guidelines 2015. 4 The potential effect of infratentorial lesions on disability was indicated by both cohorts (London I and Barcelona) 26, 33 and by the study of Swanton 32 on ON (London II). However, in case of ON it was shown by Swanton There was a nonsignificant trend that development of SPMS was associated with a higher T2 lesion volume increase over 20 years than in patients who remained RR (P = 0.07). T2 lesion volume increase in patients diagnosed with SPMS appeared higher than in those with RRMS over the first 5 years (P = 0.008). 6 Results beyond 15 years of follow-up are restricted to only this study (London I). Results on MRI and mortality were not reported. Here, studies with an even longer follow-up than 20 years are needed.
There were no studies, which analysed the prognostic value of brain atrophy with our search criteria, although a combination of inflammatory and degenerative measures might lead to a better matching of MRI parameters and prognosis. 44 Di Filippo evaluated brain atrophy in a cohort with n = 99 CIS patients and found a higher atrophy rate in patients with a later CDMS diagnosis, but brain atrophy rate was not an independent predictor of disability at 6 years. 45 This was also concluded by a recent Australian study analysing the corpus callosum area in n = 143 CIS patient with a follow-up of 5 years. 46 In a sample from Barcelona (n = 54), a significant association between lower grey matter volume and disability after 15 years was found. 47 The analysis by Brownlee 48 of n = 131
nonspinal CIS patients of the London II cohort respective of the relevance of spinal cord atrophy and lesions indicates that the upper cervical cord cross-sectional area is an independent disability predictor at 5 years. Work is still needed to clarify the independent and interaction impact of brain and upper cervical cord atrophy as potential prognostic markers. 47 While higher brain lesion load, and in particular infratentorial lesions, appears to be linked with longer-term disability following a CIS, correlations of early brain lesion loads and later disability still only explain a small proportion of disability. Similarly, it is difficult to define thresholds that can be used at an individual level in clinical practice, as there is no definitive cut-off above which functionally significant disability is certain. As such, in the absence of robust prognostic models of longer-term disability following a CIS, it is still important to recognize that at an individual level neither CIS nor MS outcomes can be reliably predicted. Further, a publication bias could have influenced the results as studies reporting negative results might have not been published. As we did not search systematically for grey literature, we could have missed relevant studies. However, we checked the references of all included studies to detect further relevant studies.
| LI M ITATI O N S
| CON CLUS ION
There are very few long-term CIS data sets, but from these we conclude that following a CIS, the number or volume of T2 MRI brain lesions has some prognostic value for disability at 5-7 years, and infratentorial lesions seem to be of particular relevance. Further work is required to determine whether other MRI measures, such as brain atrophy, have a higher predictive potential.
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